Novartis questions Indian patent law provisions

... Swiss pharmaceutical giant Novartis has filed a suit in the high court of Chennai in south India contesting the rejection of its patent application concerning its anti-cancer drug Glivec. A division bench of the court is hearing the issue, a decision on which will have a major impact on the generic medicine industry, which will in turn impact health care not only in India but most of the developing and underdeveloped countries. ...